Media Contact: pr@dnamedinstitute.com
NASA selects DNA Medicine Institute's Nanoscale Diagnostics Technology for Phase II SBIR
Funding to support development of novel reagents for point-of-care fingerstick diagnostics Cambridge, MA, January 28, 2010--DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small...